肺母细胞瘤1例及文献复习
Pulmonary Blastoma: A Case Report and Literature Review
DOI: 10.12677/acm.2025.15113102, PDF, HTML, XML,   
作者: 王 鑫:西安医学院研究生工作部,陕西 西安;李文生*:陕西省人民医院病理科,陕西 西安
关键词: 肺母细胞瘤肺癌肺原发肿瘤病理诊断Pulmonary Blastoma Lung Cancer Primary Pulmonary Tumor Pathological Diagnosis
摘要: 肺母细胞瘤是一种罕见肿瘤,本文报道1例发生在成人的肺母细胞瘤;患者,男,59岁,发现右肺上叶占位性病变,就诊于我院,行CT平扫示:右肺上叶尖段见实性结节影。手术完整切除肿物送病理检查。镜下见:由低级别的胎儿型腺癌和原始间充质成分构成,伴异源性成分(软骨肉瘤),胎儿型腺癌特点是假复层柱状细胞组成,似子宫内膜样癌,核小、均匀、圆形至椭圆形胞浆透明至轻度嗜酸性,具有核下空泡。间质成分为致密的原始卵圆型细胞,具有高的核/浆比,散布在纤维或黏液样背景之中。免疫组化染色:间质成分表达Vimentin、胎儿型腺癌成分表达CK。病理诊断:肺母细胞瘤,伴异源性成分(软骨肉瘤)。肺母细胞瘤罕见,需要提高对此病的病理形态特征认识,避免误诊、漏诊。
Abstract: Pulmonary blastoma is an extremely rare neoplasm. We present one case occurring in an adult. A 59-year-old man was found to have a space-occupying lesion in the right upper lobe and was admitted to our hospital. Contrast-enhanced CT showed a solid nodule in the apical segment of the right upper lobe. The tumor was completely resected and submitted for pathological examination. Microscopically, the lesion was composed of low-grade fetal adenocarcinoma and primitive mesenchymal components accompanied by heterologous elements (chondrosarcoma). The fetal adenocarcinoma consisted of pseudostratified columnar cells resembling endometrioid carcinoma; the nuclei were small and uniform, round to oval, with clear to lightly eosinophilic cytoplasm and subnuclear vacuoles. The mesenchymal component was formed by dense primitive ovoid cells with a high nuclear-to-cytoplasmic ratio, scattered in a fibrous or myxoid background. Immunohistochemistry showed that the mesenchymal component was positive for vimentin, whereas the fetal adenocarcinoma component was positive for CK. Pathological diagnosis: pulmonary blastoma with heterologous component (chondrosarcoma). Because pulmonary blastoma is rare, greater awareness of its pathological morphology is required to avoid misdiagnosis and missed diagnosis.
文章引用:王鑫, 李文生. 肺母细胞瘤1例及文献复习[J]. 临床医学进展, 2025, 15(11): 330-334. https://doi.org/10.12677/acm.2025.15113102

1. 引言

肺母细胞瘤(Pulmonary Blastoma, PB)是一种罕见的双相性肺原发的恶性肿瘤。发病年龄范围较广,但以中青年为主。临床症状多不典型,常见的有咳嗽、咯血、胸痛、呼吸困难、发热、体重减轻和反复肺炎。由于其模糊的临床表现和罕见性,给诊断带来了挑战。确诊依赖于病理检查,需在切除标本中识别出肿瘤的上皮成分和间叶成分。术前通过支气管镜或细针穿刺活检可能有助于诊断。本文收集1例肺母细胞瘤病例,并结合国内外文献,探讨其临床特点及病理特征,以提高对该病的认知和诊断水平。

2. 病例报告

患者男性,59岁,吸烟史39年,每天约20支,半年前因“咳嗽”来我院行胸部CT平扫示:右肺上叶尖段见实性结节、肿块影,呈分叶状改变,部分周围可见索条及毛刺影,未予特殊处理;半月前来我院复查胸部CT薄层扫描示:右肺上叶尖段见实性结节影,周围可见索条及毛刺影;右肺上叶尖段见肿块影,呈分叶状改变,界清,较前明显增大,考虑肿瘤性病变;遂于我院呼吸科就诊予支气管镜检查未见明显异常,病理未见癌细胞;进一步行CT引导下穿刺活检病理示:(右肺上叶)送检穿刺组织内见低分化恶性肿瘤,结合免疫组化,倾向癌肉瘤,部分细胞伴神经内分泌分化。免疫组化:CK、Vimentin、TTF-1、Syn、CD56、LCK、INSM-1、desmin阳性表达;CK7、CgA、CK5/6、P63、LCA、P40、HCK、NapsinA、CD34、SMA、S-100阴性表达;Ki-67指数约70%。遂行手术,术中探查见右肺上叶尖段与胸顶粘连,右肺上叶可扪及大小约2 × 1.5 cm及4.0 × 2.5 cm质硬肿物两处,纵隔可见肿大淋巴结,余肺未见明显异常,行右肺上叶切除术完整切除肿物送病理检查,并清扫纵隔淋巴结(第2、4、7、10、11组)。

病理检查:大体示:右肺上叶,体积15 × 12.5 × 4 cm,切面见灰白灰褐色肿物一枚,体积1.6 × 1.5 × 1.9 cm,切面灰白灰褐色,质中(图1);镜下见:由低级别的胎儿型腺癌(图2(b))和原始间充质成分(图2(c))构成,伴异源性成分(软骨肉瘤) (图2(a)),胎儿型腺癌特点是假复层柱状细胞组成,似子宫内膜样癌,核小、均匀、圆形至椭圆形胞浆透明至轻度嗜酸性,具有核下空泡。间质成分为致密的原始卵圆型细胞,具有高的核/浆比,散布在纤维或黏液样背景之中。免疫组化:间质成分表达Vimentin (图2(e))、胎儿型腺癌成分表达CK (图2(d))、

TTF-1、β-catenin、Desmin、CD99、Syn、INSM-1、SALL4、FLi-1均阳性表达,CK7、NapsinA、CK5/6、P40、P63、EGFR、HMB45、CD56、CgA、NKX2.2均阴性表达。分子检测结果显示存在CDKN2A、SDHB、DICER1突变。

3. 随访

最终病理诊断为“右肺上叶”肺母细胞瘤,伴异源性成分(软骨肉瘤),pTNM分期:pT2bN0Mx。患者术后七月余,术后未进行辅助治疗,现无瘤生存。

注:切面见体积1.6 × 1.5 × 1.9 cm灰白灰褐色肿物一枚。

Figure 1. Gross appearance of pulmonary blastoma

1. 肺母细胞瘤的大体观

注:(a) 异源性软骨肉瘤成分(HE 200×);(b) 胎儿型腺癌成分(HE 200×);(c) 间质成分(HE 200×);(d) 胎儿型腺癌成分表达CK (EnVision 200×);(e) 间质成分表达Vimentin (EnVision 200×)。

Figure 2. Microscopic morphology and immunohistochemical staining results of pulmonary blastoma

2. 肺母细胞瘤的镜下形态及免疫组织化学染色结果

4. 讨论

肺母细胞瘤(Pulmonary Blastoma, PB)是一种罕见的原发性肺部肿瘤,它仅占所有原发性肺部肿瘤的0.25~1% [1],男女比例为2:5 [2]。临床表现通常比较模糊,包括咳嗽、带血痰、胸闷、呼吸困难和胸痛。大约40%的患者没有症状,在胸片上偶然发现肿瘤[3]。成人发病可能与吸烟有关[1]。肺母细胞瘤是由原始上皮成分和原始间叶组织构成,原始上皮成分主要为低级别胎儿型腺癌,局灶可出现高级别胎儿型腺癌或分化成熟的腺癌。43%~60%的病例中可见桑葚样结构;散在神经内分泌细胞及小细胞癌成分见于个别报道。原始间叶组织为在黏液或纤维性背景中紧密排列的圆形细胞,并有向成熟纤维母细胞分化的趋势,异源性成分如骨肉瘤、软骨肉瘤、横纹肌肉瘤见于25%的病例,卵黄囊瘤、畸胎瘤、精原细胞瘤、胚胎性癌及恶性黑色素瘤成分亦可在少数病例见到[4]。PB可分为三个组织学类别:一个双相型(经典双相PB (CBPB)和两个单相型(高分化胎儿腺癌和胸膜肺母细胞瘤) [5]

本病例镜下见低级别的胎儿型腺癌和原始间充质成分,伴异源性成分(软骨肉瘤),胎儿型腺癌特点是假复层柱状细胞组成,似子宫内膜样癌,核小、均匀、圆形至椭圆形胞浆透明至轻度嗜酸性,具有核下空泡。间质成分为致密的原始卵圆型细胞,具有高的核/浆比,散布在纤维或黏液样背景之中。免疫组化染色:间质成分表达Vimentin、胎儿型腺癌成分表达CK,β-catenin膜阳性。结合镜下形态及免疫组化结果,最终诊断为肺母细胞瘤,伴异源性成分(软骨肉瘤)。因本例随访时间较短,存在一定的局限性。

PB需与肺胎儿型腺癌、滑膜肉瘤和胸膜肺母细胞瘤鉴别。① 肺胎儿型腺癌,由复杂的、多分支的管状腺体构成[6],间质稀少,而本例PB由原始上皮和间叶成分构成,上皮排列呈腺管状,散在分布于间叶成分中。间叶成分表达Vimentin;② 滑膜肉瘤,由束状排列的梭形细胞和胶原化或黏液样变的间质构成;双相型可见腺样结构,上皮样成分为非胎儿型腺癌形态。青少年及成人,四肢关节旁多见,偶见于肺/胸膜。而本例上皮成分为胎儿型腺癌成分。此外,免疫组化滑膜肉瘤TLE1核弥漫阳性,CD99膜阳性,并常有SS18-SSX异位;③ 胸膜肺母细胞瘤,由恶性胚胎性间充质构成,或伴有陷入的非肿瘤性上皮,不存在恶性上皮成分。本例PB由低级别的胎儿型腺癌和原始间充质成分构成。胸膜肺母细胞瘤无肿瘤性上皮成分是与肺母细胞瘤鉴别的要点。

PB没有特异性的血清肿瘤标志物[7]。CTNNB1突变和β-catenin的表达是PB发展的常见机制。CTNNB1基因测序有助于鉴别PB和其他类型的肺癌;而儿童胸膜肺母细胞瘤的发生与DICER1基因突变有关[8] [9]。此外,有研究表明DICER1突变是成人肺母细胞瘤的关键分子驱动事件,提示其属于DICER1相关胚胎性肿瘤谱系,并为精准诊疗提供依据[10]。DICER1双等位突变通过“胚系截短 + 体细胞RNase IIIb热点错义”模式扰乱miRNA加工、激活RAS-MAPK通路,驱动成人肺母细胞瘤的胚胎性肿瘤发生[9]。DICER1突变通过激活RAS-MAPK等通路,为成人肺母细胞瘤提供靶向MEK抑制剂等个体化精准治疗新思路[11]β-catenin基因的突变与结肠、皮肤、软组织、子宫内膜和肝脏等的肿瘤发生有关[12],而它与肺癌发展的关系是罕见的[9],大多数常规肺癌显示β-catenin的膜定位[13] [14]。最近的研究表明,肿瘤中的桑椹胚形成与Wnt信号通路的潜在激活有关,从而导致β-catenin的过度积累[15]-[17]。此外,在PB中检测到EGFR突变,选定的PB患者EGFR靶向治疗有效[14]

综上所述,PB是一种罕见的肺原发肿瘤,临床症状模糊。确诊依赖于手术全切标本病理检查,HE镜下形态学结合免疫组化染色及基因检测有助于准确病理诊断。

声 明

该病例报道已获得病人的知情同意。

NOTES

*通讯作者。

参考文献

[1] Wang, Y., Zhang, J., Chu, X., Liu, Y., Li, F., Wang, Z., et al. (2014) Diagnosis and Multi-Modality Treatment of Adult Pulmonary Plastoma: Analysis of 18 Cases and Review of Literature. Asian Pacific Journal of Tropical Medicine, 7, 164-168. [Google Scholar] [CrossRef] [PubMed]
[2] Adluri, R.K.P., Boddu, S.R., Martin-Ucar, A., Duffy, J.P., Beggs, F.D. and Morgan, W.E. (2006) Pulmonary Blastoma—A Rare Tumor with Variable Presentation. European Journal of Cardio-Thoracic Surgery, 29, 236-239. [Google Scholar] [CrossRef] [PubMed]
[3] Smyth, R.J., Fabre, A., Dodd, J.D., Bartosik, W., Gallagher, C.G. and McKone, E.F. (2014) Pulmonary Blastoma: A Case Report and Review of the Literature. BMC Research Notes, 7, Article No. 294. [Google Scholar] [CrossRef] [PubMed]
[4] 张杰, 邵晋晨, 朱蕾. 2015版WHO肺肿瘤分类解读[J]. 中华病理学杂志, 2015, 44(9): 619-624.
[5] Manivel, J.C., Priest, J.R., Watterson, J., Steiner, M., Woods, W.G., Wick, M.R., et al. (1988) Pleuropulmonary Blastoma the So-Called Pulmonary Blastoma of Childhood. Cancer, 62, 1516-1526. [Google Scholar] [CrossRef
[6] 周发忱, 陈丹, 张丽芝, 等. β-Catenin核阴性低级别肺胎儿型腺癌1例[J]. 大连医科大学学报, 2020, 42(4): 372-374.
[7] Dixit, R., Joshi, N. and Dave, L. (2014) Biphasic Pulmonary Blastoma: An Unusual Presentation with Chest Wall, Rib, and Pleural Involvement. Lung India, 31, 87-89. [Google Scholar] [CrossRef] [PubMed]
[8] Nakatani, Y., Miyagi, Y., Takemura, T., Oka, T., Yokoi, T., Takagi, M., et al. (2004) Aberrant Nuclear/Cytoplasmic Localization and Gene Mutation of β-Catenin in Classic Pulmonary Blastoma: β-Catenin Immunostaining Is Useful for Distinguishing between Classic Pulmonary Blastoma and a Blastomatoid Variant of Carcinosarcoma. The American Journal of Surgical Pathology, 28, 921-927. [Google Scholar] [CrossRef] [PubMed]
[9] Kock, L., Wu, M.K. and Foulkes, W.D. (2019) Ten Years of DICER1 Mutations: Provenance, Distribution, and Associated Phenotypes. Human Mutation, 40, 1939-1953. [Google Scholar] [CrossRef] [PubMed]
[10] de Kock, L., Bah, I., Brunet, J., Druker, H., Astigarraga, I., Bosch-Barrera, J., et al. (2016) Somatic DICER1 Mutations in Adult-Onset Pulmonary Blastoma. European Respiratory Journal, 47, 1879-1882. [Google Scholar] [CrossRef] [PubMed]
[11] Zhang, L., Mallinger, P.H.R., Zhou, S., Makri, S.C., Gross, J.M., Lucas, C.G., et al. (2025) RAS Pathway Targeted Therapy in Patients with DICER1-Associated Sarcomas. npj Precision Oncology, 9, Article No. 232. [Google Scholar] [CrossRef] [PubMed]
[12] Polakis, P. (2000) Wnt Signaling and Cancer. Genes & Development, 14, 1837-1851. [Google Scholar] [CrossRef
[13] Sunaga, N., Kohno, T., Kolligs, F.T., Fearon, E.R., Saito, R. and Yokota, J. (2001) Constitutive Activation of the Wnt Signaling Pathway Byctnnb1 (β-Catenin) Mutations in a Subset of Human Lung Adenocarcinoma. Genes, Chromosomes and Cancer, 30, 316-321. [Google Scholar] [CrossRef
[14] Nakatani, Y., Masudo, K., Miyagi, Y., Inayama, Y., Kawano, N., Tanaka, Y., et al. (2002) Aberrant Nuclear Localization and Gene Mutation of β-Catenin in Low-Grade Adenocarcinoma of Fetal Lung Type: Up-Regulation of the Wnt Signaling Pathway May Be a Common Denominator for the Development of Tumors That Form Morules. Modern Pathology, 15, 617-624. [Google Scholar] [CrossRef] [PubMed]
[15] Gamachi, A., Kashima, K., Daa, T., Nakatani, Y., Tsujimoto, M. and Yokoyama, S. (2003) Aberrant Intranuclear Localization of Biotin, Biotin-Binding Enzymes, and β-Catenin in Pregnancy-Related Endometrium and Morule-Associated Neoplastic Lesions. Modern Pathology, 16, 1124-1131. [Google Scholar] [CrossRef] [PubMed]
[16] Nakatani, Y. (2004) Biotin-Rich, Optically Clear Nuclei Express Estrogen Receptor-β: Tumors with Morules May Develop under the Influence of Estrogen and Aberrant β-Catenin Expression. Human Pathology, 35, 869-874. [Google Scholar] [CrossRef] [PubMed]
[17] Macher-Goeppinger, S., Penzel, R., Roth, W., Dienemann, H., Thomas, M., Schnabel, P.A., et al. (2011) Expression and Mutation Analysis of EGFR, C-Kit, and β-Catenin in Pulmonary Blastoma. Journal of Clinical Pathology, 64, 349-353. [Google Scholar] [CrossRef] [PubMed]